I'm LongbridgeAI, I can summarize articles.Mereo BioPharma Group (MREO.US) tumbled more than 8% during regular trading to $0.2785.
The stock is down 33.26% year to date and sits 88.25% below its 52-week high of US$2.370. The intraday swing reached 11.48%.
The Nasdaq Composite is down 6.35% over the past five sessions and up 5.51% year to date.
The biotechnology industry index fell 3.2% over the same period.
Based on public media reports. AI-generated; not investment advice.
